Biote Reports First Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- First Financial to acquire Hickory Point Bank in $111.3M deal
- McKesson reports cybersecurity incident affecting its information systems
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- BioNTech ends colorectal cancer mRNA therapy trial early
biote Corp. (BTMD) PT Raised to $10 at Roth/MKM
May 8, 2024 7:11 AM EDTRoth/MKM analyst George Kelly raised the price target on biote Corp. (NASDAQ: BTMD) to $10.00 (from $9.00) while maintaining a Buy rating.
The analyst comments "We like BTMD. 1Q24 results exceeded our estimates, procedure revenue stepped up sequentially and growth appears to have stabilized,... More
